GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » Pretax Margin %

Quantum Genomics (STU:2QG) Pretax Margin % : 6,408.90% (As of Dec. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Quantum Genomics's Pre-Tax Income for the six months ended in Dec. 2022 was €-18.71 Mil. Quantum Genomics's Revenue for the six months ended in Dec. 2022 was €-0.29 Mil. Therefore, Quantum Genomics's pretax margin for the quarter that ended in Dec. 2022 was 6,408.90%.

The historical rank and industry rank for Quantum Genomics's Pretax Margin % or its related term are showing as below:


STU:2QG's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.7
* Ranked among companies with meaningful Pretax Margin % only.

Quantum Genomics Pretax Margin % Historical Data

The historical data trend for Quantum Genomics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Pretax Margin % Chart

Quantum Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -1,152.37 -16,538.79 -5,038.18

Quantum Genomics Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -657.11 -242.17 513.39 -1,311.82 6,408.90

Competitive Comparison of Quantum Genomics's Pretax Margin %

For the Biotechnology subindustry, Quantum Genomics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum Genomics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's Pretax Margin % falls into.



Quantum Genomics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Quantum Genomics's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-30.481/0.605
=-5,038.18 %

Quantum Genomics's Pretax Margin for the quarter that ended in Dec. 2022 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-18.714/-0.292
=6,408.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum Genomics  (STU:2QG) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Quantum Genomics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (STU:2QG) Business Description

Traded in Other Exchanges
N/A
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines